Strategies to decrease oxidative stress biomarker levels in human medical conditions: A meta-analysis on 8-iso-prostaglandin F

Redox Biol. 2018 Jul:17:284-296. doi: 10.1016/j.redox.2018.05.003. Epub 2018 May 9.

Abstract

The widespread detection of elevated oxidative stress levels in many medical conditions has led to numerous efforts to design interventions to reduce its effects. Efforts have been wide-ranging, from dietary changes to administration of antioxidants, supplements, e.g., omega-3-fatty acids, and many medications. However, there is still no systemic assessment of the efficacy of treatments for oxidative stress reduction across a variety of medical conditions. The goal of this meta-analysis is, by combining multiple studies, to quantitate the change in the levels of the popular oxidative stress biomarker 8-iso-prostaglandin F (8-iso-PGF) after a variety of treatment strategies in human populations. Nearly 350 unique publications with 180 distinct strategies were included in the analysis. For each strategy, the difference between pre- or placebo and post-treatment levels calculated using Hedges' g value of effect. In general, administration of antibiotics, antihyperlipidemic agents, or changes in lifestyle (g = - 0.63, - 0.54, and 0.56) had the largest effect. Administration of supplements, antioxidants, or changes in diet (g = - 0.09, - 0.28, - 0.12) had small quantitative effects. To fully interpret the effectiveness of these treatments, comparisons to the increase in g value for each medical condition is required. For example, antioxidants in populations with coronary artery disease (CAD) reduce the 8-iso-PGF levels by g = - 0.34 ± 0.1, which is quantitatively considered a small effect. However, CAD populations, in comparison to healthy populations, have an increase in 8-iso-PGF levels by g = 0.38 ± 0.04; therefore, the overall reduction of 8-iso-PGF levels is ≈ 90% by this treatment in this specific medical condition. In conclusion, 8-iso-PGF levels can be reduced not only by antioxidants but by many other strategies. Not all strategies are equally effective at reducing 8-iso-PGF levels. In addition, the effectiveness of any strategy can be assessed only in relation to the medical condition investigated.

Publication types

  • Meta-Analysis
  • Research Support, N.I.H., Intramural

MeSH terms

  • Antioxidants / therapeutic use
  • Biomarkers / blood*
  • Coronary Artery Disease / blood*
  • Coronary Artery Disease / genetics
  • Coronary Artery Disease / prevention & control
  • Dietary Supplements
  • Dinoprost / analogs & derivatives*
  • Dinoprost / blood
  • Dinoprost / genetics
  • Genetics, Population
  • Humans
  • Lipid Peroxidation / genetics
  • Oxidation-Reduction / drug effects
  • Oxidative Stress / genetics*

Substances

  • Antioxidants
  • Biomarkers
  • 8-epi-prostaglandin F2alpha
  • Dinoprost